Online Inquiry
Cat.#: ACPP-1335
| Despition | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1512 | Human UBE2K Protein (AC1512) | 2 µg | inquiry |
| ACPP-1551 | Human PEDF Protein, His (AC1551) | 5 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
| ACPP-1212 | PAX8 Blocking Peptide (AC1212) | 250 µg | inquiry |
| ACPP-1805 | Human NTS Protein (AC1805) | 5 µg | inquiry |
| ACPP-1587 | Human TMED10 Protein (AC1587) | 2 µg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1677 | Mouse S100A8 Protein (AC1677) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.